Bridgefront Capital’s Johnson & Johnson JNJ Stock Holding History

Bridgefront Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Buy	+7,888	New	+$1.84M	0.53%	29
2026 Q1	–	Sell	-3,561	Closed	-$737K	–	652
2025 Q4	$737K	Sell	3,561 -2,677	-43%	-$529K	0.19%	186
2025 Q3	$1.16M	Buy	+6,238	New	+$1.07M	0.34%	65
2025 Q1	–	Sell	-2,689	Closed	-$389K	–	743
2024 Q4	$389K	Buy	+2,689	New	+$417K	0.13%	279
2024 Q3	–	Sell	-4,306	Closed	-$629K	–	626
2024 Q2	$629K	Buy	4,306 +1,079	+33%	+$160K	0.26%	122
2024 Q1	$510K	Buy	+3,227	New	+$514K	0.39%	70
2023 Q4	–	Sell	-1,418	Closed	-$221K	–	466
2023 Q3	$221K	Buy	+1,418	New	+$234K	0.15%	299
2023 Q2	–	Sell	-8,791	Closed	-$1.36M	–	575
2023 Q1	$1.36M	Buy	8,791 +5,921	+206%	+$956K	0.83%	8
2022 Q4	$507K	Buy	2,870 +779	+37%	+$135K	0.35%	95
2022 Q3	$342K	Buy	+2,091	New	+$354K	0.35%	105
2022 Q2	–	Sell	-3,950	Closed	-$700K	–	377
2022 Q1	$700K	Buy	+3,950	New	+$672K	0.86%	18
2021 Q2	–	Sell	-7,922	Closed	-$1.3M	–	757
2021 Q1	$1.3M	Buy	+7,922	New	+$1.28M	0.41%	29

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bridgefront Capital's JNJ Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 7,888 shares worth $2M. The stake represents 0.53% of the portfolio and ranks #29 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in JNJ as recently as Q4 2025.

Bridgefront Capital first reported a position in JNJ in Q1 2021 and has held it in 12 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Bridgefront Capital held 7,888 shares of Johnson & Johnson worth $2M as of Q2 2026.
Johnson & Johnson was a new Bridgefront Capital position in Q2 2026.
Johnson & Johnson made up 0.53% of Bridgefront Capital's portfolio in Q2 2026, its #29 holding.
Bridgefront Capital first reported a position in Johnson & Johnson in Q1 2021 and has held it in 12 quarters since.
4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.